IRB #

STUDY00019992

Title

[NCI CIRB] MATCH - EAY131 - Molecular Analysis for Therapy Choice (MATCH)

Principal Investigator

Christopher Ryan

Study Purpose

The purpose of this trial is to establish whether participants with specific gene changes or mutations are likely to benefit if treated with study drugs targeting the genetic pathway.

Medical Condition(s)

Bladder cancer
Breast cancer
Cervical cancer
Colorectal cancer
Glioblastoma (GBM)
Glioma
Head and neck cancer
Lung cancer
Melanoma
Ovarian cancer
Pancreas cancer
Prostate cancer
Stomach cancer
Thyroid cancer
Uterine cancer

Eligibility Criteria

- Participants must have documented solid tumors, lymphoma, or multiple myeloma
- Participants must have progressed following at least 1 line of standard treatment
- Participants must receive lab results indicating a "rare variant" of interest for the study

Age Range

18 - 100

Healthy Volunteers Needed

No

Duration of Participation

Participants will be on study for up to 3 years from the time of study entry through follow up.

Minors Included

No

Contact

Knight Information Line - trials@ohsu.edu or 503-494-1080

Sponsor

ECOG-ACARIN

Recruitment End

06/30/2022

Compensation Provided

No


Go Back